The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

We are now working to make pimicotinib available to patients in China as quickly as possible, as we continue to progress applications with regulatory authorities in additional markets.” TGCT is a rare ...

Research shows male microglia are more sensitive to disrupted CSF1R signaling, uncovering potential links to sex-based disparities in neurological disorders. Study: The microglial response to ...

Pimicotinib is the first Class 1 chemical drug approved in China for the treatment of TGCT, with its approval based on results from the global Phase 3 MANEUVER study, in which the drug demonstrated ...